U.S. Markets closed

Healthcare: Drug Pricing Concerns Weigh on Valuations, Creating Opportunities

Damien Conover, CFA (damien.conover@morningstar.com)

Innovation, consolidation, and a mixed regulatory picture for healthcare stocks in the second quarter.